KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Receivables - Net (2016 - 2025)

Cvs Health's Receivables - Net history spans 17 years, with the latest figure at $39.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 9.08% year-over-year to $39.8 billion, compared with a TTM value of $39.8 billion through Dec 2025, up 9.08%, and an annual FY2025 reading of $39.8 billion, up 9.08% over the prior year.
  • Receivables - Net for Q4 2025 was $39.8 billion at Cvs Health, down from $43.9 billion in the prior quarter.
  • The five-year high for Receivables - Net was $43.9 billion in Q3 2025, with the low at $2.3 billion in Q2 2023.
  • Average Receivables - Net over 5 years is $22.2 billion, with a median of $24.9 billion recorded in 2021.
  • Year-over-year, Receivables - Net crashed 89.05% in 2022 and then skyrocketed 1310.5% in 2024.
  • Tracing CVS's Receivables - Net over 5 years: stood at $24.4 billion in 2021, then crashed by 89.05% to $2.7 billion in 2022, then skyrocketed by 1216.41% to $35.2 billion in 2023, then grew by 3.53% to $36.5 billion in 2024, then increased by 9.08% to $39.8 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Receivables - Net are $39.8 billion (Q4 2025), $43.9 billion (Q3 2025), and $40.7 billion (Q2 2025).